J. Morris

发表

Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands.

C. Spitzweg, J. Goellner, W. Joba, 1999, The Journal of clinical endocrinology and metabolism.

Molecular cloning of murine FLT and FLT4.

D. Merberg, R. Kriz, K. Kelleher, 1993, Oncogene.

The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.

O. Wildner, J. Morris, J. Morris, 2000, Cancer research.

Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.

D. Tindall, M. O’Connor, C. Spitzweg, 2000, Cancer research.

Development of monoclonal antibodies against the human sodium iodide symporter: immunohistochemical characterization of this protein in thyroid cells.

J. Goellner, B. Mciver, J. Morris, 1999, The Journal of clinical endocrinology and metabolism.

Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.

D. Tindall, C. Spitzweg, B. Mciver, 1999, Cancer research.

Thyroid iodine transport.

C. Spitzweg, J. Morris, A. Heufelder, 2000, Thyroid : official journal of the American Thyroid Association.

Cloning of the mouse sodium iodide symporter.

C. Spitzweg, D. S. Dean, J. Morris, 2001, Thyroid : official journal of the American Thyroid Association.

Structure and function of the TSH receptor: its suitability as a target for radiotherapy.

J. Morris, John C. Morris, 1997, Thyroid : official journal of the American Thyroid Association.

Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B.

J. Herndon, M. Green, S. Fleishman, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Renal metastases from thyroid papillary carcinoma: study of sodium iodide symporter expression.

M. Merino, R. Smallridge, J. Reynolds, 2001, Thyroid : official journal of the American Thyroid Association.

Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake.

I. Hay, J. Goellner, J. Morris, 2001, The Journal of clinical endocrinology and metabolism.

The vascular flora of Boiling Spring Lakes Preserve, Brunswick County, North Carolina

J. Morris, 2009 .

α-Fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma

R. Senekowitsch-Schmidtke, B. Göke, L. Mohr, 2008, Gene Therapy.

Effect of increased viral replication and infectivity enhancement on radioiodide uptake and oncolytic activity of adenovirus vectors expressing the sodium iodide symporter

M. Yamamoto, J. Morris, J. Davydova, 2013, Cancer Gene Therapy.

Targeting PP2A and proteasome activity ameliorates features of allergic airway disease in mice

A. Ammit, P. M. Nair, A. Clark, 2017, Allergy.

iodobenzylguanidine, [F]fluorodopamine, and [H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors

A. Tischler, A. Fojo, K. Pacak, 2011 .

Sequential purification of human apolipoprotein B-100, albumin, and fibrinogen by immunoaffinity chromatography for measurement of protein synthesis.

K. Nair, A. Fu, J. Morris, 1997, Analytical biochemistry.

Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.

I. Hay, J. Morris, N. Jiang, 1988, Mayo Clinic proceedings.

An unusual case of inappropriate secretion of thyrotropin: neoplastic or nonneoplastic?

J. Morris, M. R. Castro, D. Kocher, 2000, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

The protumorigenic potential of FTY720 by promoting extramedullary hematopoiesis and MDSC accumulation

Y. Ma, R. Guo, G. Han, 2017, Oncogene.

Cryptic trinucleotide repeat polymorphism in the POMC gene.

J. Morris, P. Lowry, D. Savva, 1994, Human molecular genetics.

Reduced expression of a naturally deleted form of human proopiomelanocortin complementary deoxyribonucleic acid after transfection into Chinese hamster ovary cells.

J. Morris, P. Lowry, D. Savva, 1995, Endocrinology.

Enzyme/prodrug-based tumor vaccination: all politics (and immunity) are local.

J. Morris, 1999, Journal of the National Cancer Institute.

TCR vbeta usage of TSH receptor-specific CD4+ T cells in Graves' disease patients and healthy humans.

J. Morris, D. Mccormick, B. Conti-Fine, 1997, Journal of autoimmunity.

Synthesis of highly enantio-enriched stereoisomers of hydroxy-GR24.

J. Morris, C. McErlean, 2016, Organic & biomolecular chemistry.

Therapy of peritoneal carcinomatosis from colon cancer with oncolytic adenoviruses

O. Wildner, J. Morris, Oliver Wildner, 2000, The journal of gene medicine.

Estimation of the Nearshore Bathymetry using Remote Sensing Techniques: Combining Beach Wizard and cBathy

J. Morris, 2013 .

Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer

R. Vile, K. Harrington, B. Göke, 2005, Gene Therapy.

Dexamethasone enhances the cytotoxic effect of radioiodine therapy in prostate cancer cells expressing the sodium iodide symporter.

B. Göke, C. Spitzweg, J. Morris, 2004, The Journal of clinical endocrinology and metabolism.

Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells.

D. Tindall, B. Göke, C. Spitzweg, 2003, Endocrinology.

Sodium iodide symporter (NIS) gene expression in human placenta.

R. Mortimer, J. Morris, A. M. Mitchell, 2001, Placenta.

Approaches to gene therapy with sodium/iodide symporter

C. Spitzweg, J. Morris, John C. Morris, 2001, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Thyrotropin receptor-specific antibodies in BALB/cJ mice with experimental hyperthyroxinemia show a restricted binding specificity and belong to the immunoglobulin G1 subclass.

B. Prabhakar, J. Morris, J. Dallas, 1995, Endocrinology.

Purification and use of recombinant glycosylphosphatidylinositol-phospholipase C.

P. T. Englund, A. Al-Qahtani, J. Morris, 1995, Methods in enzymology.

Capillary zone electrophoresis separation of recombinant human interleukin-3 and related proteins.

F. S. Stover, J. Morris, C. Demarest, 1989, Preparative biochemistry.

Polymerase chain reaction for detection of Toxoplasma gondii.

J. Morris, R. Holliman, J. Johnson, 1990, Journal of medical microbiology.

Optimal use of blood tests for assessment of thyroid function.

M. Sugawara, L. Wartofsky, S. Bigos, 1993, JAMA.

Expression of the sodium iodide symporter in human kidney.

C. Spitzweg, J. Goellner, J. Morris, 2001, Kidney international.

Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer.

P. Roche, S. Jhiang, J. Goellner, 1999, The Journal of endocrinology.

Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells.

C. Spitzweg, W. Joba, J. Morris, 1999, Thyroid : official journal of the American Thyroid Association.

Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice

M. O’Connor, R. Dwyer, S. Gendler, 2006, Gene Therapy.

Replication of kinetoplast DNA: an update for the new millennium.

Zefeng Wang, P. T. Englund, M. Klingbeil, 2001, International journal for parasitology.

Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.

O. Wildner, R. Blaese, J. Morris, 1999, Human gene therapy.

Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells.

B. Göke, C. Spitzweg, M. Willhauck, 2006, The Journal of clinical endocrinology and metabolism.

Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy.

R. Vile, K. Harrington, C. Spitzweg, 2001, The Journal of clinical endocrinology and metabolism.

Lymphocytic interstitial pneumonia in patients at risk for the acquired immune deficiency syndrome.

A. Marchevsky, A. Teirstein, M. Rosen, 1987, Chest.

The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG.

L. Cole, J. Morris, S. Birken, 1991, Endocrinology.

Inhibition of GPI phospholipase C from Trypanosoma brucei by fluoro-inositol dodecylphosphonates.

P. Lei, J. Morris, K. Mensa-Wilmot, 1998, Biochemical and biophysical research communications.

Role of 2,6-Dideoxy-2,6-diaminoglucose in Activation of a Eukaryotic Phospholipase C by Aminoglycoside Antibiotics*

J. Morris, K. Mensa-Wilmot, J. C. Morris, 1997, The Journal of Biological Chemistry.

A glycosylphosphatidylinositol (GPI)-negative phenotype produced in Leishmania major by GPI phospholipase C from Trypanosoma brucei: topography of two GPI pathways

K. Chang, S. Tucker, B. McGwire, 1994, The Journal of cell biology.

Advances in recombinant gonadotropin production for use in bovine superovulation.

J. Gibbons, J. Morris, M. Hesser, 2011, Reproduction in domestic animals = Zuchthygiene.

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

O. Wildner, W. Ramsey, R. Blaese, 1999, Gene Therapy.

Rho GTPases: Anti- or Pro-neoplastic Targets?

Y. Zheng, J. Morris, Yuan Lin, 2016, Oncogene.

Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase.

O. Wildner, R. Blaese, J. Morris, 1999, Cancer research.

In vitro assessment of variables affecting the efficiency and efficacy of adenovirus-mediated gene transfer to cystic fibrosis airway epithelia.

J. Olsen, H. Ye, L. G. Johnson, 1996, Human gene therapy.

Mucoepidermoid Carcinoma of the Lung: A Case Report and Literature Review

K. Wikenheiser-Brokamp, J. Morris, N. Karim, 2013, Case reports in oncological medicine.

Trans‐complementing adenoviral vectors for oncolytic therapy of malignant melanoma

W. J. Ramsey, G. Ehninger, J. Morris, 2004, The journal of gene medicine.

Combined modality therapy for stage II and stage III pancreatic carcinoma.

A. Cooperman, J. Morris, H. Bruckner, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular cloning of the cDNA encoding a receptor tyrosine kinase-related molecule with a catalytic region homologous to c-met.

D. Merberg, R. Kriz, C. Wood, 1992, International journal of cell cloning.

Mid-Season Prediction of Wheat-Grain Yield Potential Using Plant, Soil, and Sensor Measurements

S. K. Kariuki, W. R. Raun, K. L. Martin, 2006 .

Defining the major antibody epitopes on the human thyrotropin receptor in immunized mice: evidence for intramolecular epitope spreading.

Y. Tomer, T. Davies, J. Morris, 1995, Endocrinology.

Structure-function studies of the human thyrotropin receptor. Inhibition of binding of labeled thyrotropin (TSH) by synthetic human TSH receptor peptides.

J. Morris, D. Mccormick, E. Bergert, 1993, The Journal of biological chemistry.

Generation and characterization of monoclonal antibodies to the human thyrotropin (TSH) receptor: antibodies can bind to discrete conformational or linear epitopes and block TSH binding.

B. Prabhakar, G. S. Seetharamaiah, J. Morris, 1995, Endocrinology.

Thyrotropin (TSH) interacts with multiple discrete regions of the TSH receptor: polyclonal rabbit antibodies to one or more of these regions can inhibit TSH binding and function.

R. Goldblum, B. Prabhakar, S. J. Cunningham, 1994, Endocrinology.

Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy

N. Eberhardt, S. Russell, H. Reddi, 2012, Cancer Gene Therapy.

Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter.

G. Thompson, C. Grant, J. V. van Heerden, 1999, The Journal of clinical endocrinology and metabolism.

WT1-mediated Transcriptional Activation Is Inhibited by Dominant Negative Mutant Proteins (*)

J. Licht, D. Haber, Junchang Wang, 1995, The Journal of Biological Chemistry.

Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk.

O. Wildner, J. Morris, J. Morris, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

A phase I study of intralesional administration of an adenovirus vector expressing the HSV-1 thymidine kinase gene (AdV.RSV-TK) in combination with escalating doses of ganciclovir in patients with cutaneous metastatic malignant melanoma.

O. Wildner, W. Ramsey, R. Blaese, 2000, Human gene therapy.

TSH receptor sequences recognized by CD4+ T cells in Graves' disease patients and healthy controls.

J. Morris, D. Mccormick, B. Conti-Fine, 1995, Journal of autoimmunity.

Identification of thyroid blocking antibodies and receptor epitopes in autoimmune hypothyroidism by affinity purification using synthetic TSH receptor peptides.

J. Morris, E. Bergert, W. Bryant, 1995, Autoimmunity.

Identification of epitopes and affinity purification of thyroid stimulating auto-antibodies using synthetic human TSH receptor peptides.

B. Prabhakar, J. Morris, J. Gibson, 1994, Autoimmunity.

Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.

B. Prabhakar, S. J. Cunningham, G. S. Seetharamaiah, 1996, Endocrinology.

Graves' IgG recognizes linear epitopes in the human thyrotropin receptor.

K. Burman, J. Morris, E. Nagy, 1992, Biochemical and biophysical research communications.

The sodium iodide symporter (NIS): novel applications for radionuclide imaging and treatment.

M. Schwaiger, E. Wagner, P. Nelson, 2021, Endocrine-related cancer.

Inhibition of bloodstream form Trypanosoma brucei gene expression by RNA interference using the pZJM dual T7 vector.

P. T. Englund, J. Morris, M. Drew, 2001, Molecular and biochemical parasitology.

Molecular cloning and characterization of murine interleukin-11.

D. Beier, J. Mccoy, C. Wood, 1996, Experimental hematology.

The immune response to the iodide transporter.

C. Spitzweg, J. Morris, 2000, Endocrinology and metabolism clinics of North America.

Conversion of non-iodine-concentrating differentiated thyroid carcinoma metastases into iodine-concentrating foci after anticancer chemotherapy.

J. Mechanick, J. Morris, M. Padilla, 1997, Thyroid : official journal of the American Thyroid Association.

The role of soil inference systems in digital soil assessments

B. Minasny, A. McBratney, J. Morris, 2012 .

Further characterization of the receptor-binding region of the thyroid-stimulating hormone alpha subunit: a comprehensive synthetic peptide study of the alpha-subunit 26-46 sequence.

M. Leinung, J. Morris, D. Mccormick, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Isolation and characterization of the human DTK receptor tyrosine kinase.

C. Wood, J. Morris, P. Lewis, 1994, Growth factors.

The sodium-iodide symporter.

J. Morris, C. H. Baker, Claire H. Baker, 2004, Current drug targets. Immune, endocrine and metabolic disorders.

Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.

R. Senekowitsch-Schmidtke, B. Göke, L. Mohr, 2008, Gene therapy.

Thallium-201 and iodine-131 scintigraphy in differentiated thyroid carcinoma.

J. Mechanick, D. Bergman, J. Morris, 1996, Journal of Nuclear Medicine.

Secondary structure of human interleukin-3.

J. Freeman, J. Morris, J. Mckearn, 1991, The International journal of biochemistry.

Micropreparative capillary zone electrophoresis of recombinant human interleukin-3.

J. F. Coleman, F. S. Stover, J. Morris, 1989, Preparative Biochemistry.

Clinical case seminar: Hypokalemia in a 52-year-old woman with non-small cell lung cancer.

J. Mechanick, J. Morris, 1995, Journal of Clinical Endocrinology and Metabolism.

Can Sorafenib Cause Hypothyroidism?

R. McWilliams, T. Hobday, J. Morris, 2007, Journal of chemotherapy.